CHU Toulouse
- Address
- 9 Place Lange, Toulouse, France
CHU Toulouse - ENT and Rhinology Research Center
CHU Toulouse is a leading academic medical center conducting innovative clinical research in otolaryngology and chronic sinonasal diseases. The center specializes in evaluating novel therapeutic approaches for challenging ear, nose, and throat conditions, with particular expertise in idiopathic purulent sinusitis and patient quality of life outcomes.
- Chronic rhinosinusitis and sinonasal inflammatory disorders
- Extended antibiotic therapy protocols and antimicrobial stewardship
- Quality of life assessment using validated ENT-specific instruments (SNOT-22)
The research team at CHU Toulouse focuses on rigorously designed multicentre randomised controlled trials to establish evidence-based treatment protocols for complex ear, nose and throat diseases. Their work emphasizes patient-centered outcomes and the optimization of long-term therapeutic strategies in conditions that significantly impact daily living and respiratory health.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in CHU Toulouse
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Azithromycin Efficacy in Idiopathic Purulent Oedematous Sinusitis in Adults: A Multicentre Randomised Controlled Trial | Centre Hospitalier Intercommunal Creteil | Phase III | Not Recruiting | Oct 2022 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Azithromycin | 1 | Unknown | 2022-10-06 | 2022-10-06 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.